INFLUENCE OF HYPERTHYROIDISM ON THE KINETICS OF METHIMAZOLE, PROPRANOLOL, METOPROLOL AND ATENOLOL

被引:29
作者
HALLENGREN, B
NILSSON, OR
KARLBERG, BE
MELANDER, A
TEGLER, L
WAHLINBOLL, E
机构
[1] UNIV LUND,MALMO GEN HOSP,DEPT CLIN PHARMACOL,S-21401 MALMO,SWEDEN
[2] LINKOPING UNIV HOSP,DEPT INTERNAL MED,S-58185 LINKOPING,SWEDEN
关键词
D O I
10.1007/BF00542322
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:379 / 384
页数:6
相关论文
共 27 条
[11]   ANTI-THYROID DRUGS [J].
MARCHANT, B ;
LEES, JFH ;
ALEXANDER, WD .
PHARMACOLOGY & THERAPEUTICS PART B-GENERAL & SYSTEMATIC PHARMACOLOGY, 1978, 3 (03) :305-348
[12]   COMPARATIVE INVITRO EFFECTS AND INVIVO KINETICS OF ANTI-THYROID DRUGS [J].
MELANDER, A ;
HALLENGREN, B ;
ROSENDALHELGESEN, S ;
SJOBERG, AK ;
WAHLINBOLL, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (04) :295-299
[13]   INFLUENCE OF FOOD ON BIOAVAILABILITY OF DRUGS [J].
MELANDER, A .
CLINICAL PHARMACOKINETICS, 1978, 3 (05) :337-351
[14]   EFFECTS AND PLASMA-LEVELS OF PROPRANOLOL AND METOPROLOL IN HYPER-THYROID PATIENTS [J].
NILSSON, OR ;
MELANDER, A ;
TEGLER, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (04) :315-320
[15]  
NILSSON OR, 1979, ACTA MED SCAND, V206, P21
[16]  
PRITCHARD JF, 1979, J CHROMATOGR, V162, P47, DOI 10.1016/S0378-4347(00)82062-9
[17]   EFFECTS OF THYROID-DYSFUNCTION ON PROPRANOLOL KINETICS [J].
RIDDELL, JG ;
NEILL, JD ;
KELLY, JG ;
MCDEVITT, DG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) :565-574
[18]  
RUBENFELD S, 1978, CLIN RES, V26, pA295
[19]   MEASUREMENT OF THYROXINE BY COMPETITIVE PROTEIN-BINDING [J].
SELIGSON, H ;
SELIGSON, D .
CLINICA CHIMICA ACTA, 1972, 38 (01) :199-&
[20]  
SITAR DS, 1979, CLIN INVEST MED, V2, P93